These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3582088)

  • 1. Near normalization of metabolic abnormalities by prolonged CSII in a girl with congenital lipodystrophy.
    Klar A; Corcos AP; Gross-Kieselstein E; Reifen RM; Navon P; Branski D
    Diabetes Care; 1987; 10(2):257-9. PubMed ID: 3582088
    [No Abstract]   [Full Text] [Related]  

  • 2. Congenital generalized lipodystrophy and experimental lipoatrophic diabetes in rabbits treated successfully with fenfluramine.
    Trygstad O; Foss I
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):436-48. PubMed ID: 577333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical utility of leptin therapy in metabolic dysfunction.
    Park JY; Gavrilova O; Gorden P
    Minerva Endocrinol; 2006 Jun; 31(2):125-31. PubMed ID: 16682936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis.
    Rabbone I; Barbetti F; Marigliano M; Bonfanti R; Piccinno E; Ortolani F; Ignaccolo G; Maffeis C; Confetto S; Cerutti F; Zanfardino A; Iafusco D
    Acta Diabetol; 2016 Aug; 53(4):559-65. PubMed ID: 26831749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipodystrophic diabetes treated with fenfluramine.
    Trygstad O; Seip M; Oseid S
    Int J Obes; 1977; 1(3):287-92. PubMed ID: 617340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-morning hyperglycemia in diabetic individuals treated with continuous subcutaneous insulin infusion.
    Geffner ME; Frank HJ; Kaplan SA; Lippe BM; Levin SR
    Diabetes Care; 1983; 6(2):135-9. PubMed ID: 6682750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amenorrhea, ptosis and high insulin requirement in a young girl.
    Hari Kumar KV; Kumar S
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S151-3. PubMed ID: 26482962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipodystrophy.
    Helm TN; Bisker E; Bergfeld WF
    Cutis; 2001 Feb; 67(2):163-4. PubMed ID: 11236228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy of using single-component insulin preparations in diabetes mellitus and generalized lipodystrophy].
    Gorelysheva VA; Zhdanova ES; Lobanova AM; Arbuzova MI
    Probl Endokrinol (Mosk); 1990; 36(2):52-5. PubMed ID: 2194203
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolic complications associated with use of protease inhibitors].
    Mosnier-Pudar H
    Ann Med Interne (Paris); 2000 Jun; 151(4):278-82. PubMed ID: 10922955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased binding of insulin to its receptor in patients with congenital generalized lipodystrophy.
    Oseid S; Beck-Nielsen H; Pedersen O; Sovik O
    N Engl J Med; 1977 Feb; 296(5):245-8. PubMed ID: 831106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience with treatment of insulin lipodystrophy].
    Skrobonskaia NA; Derevianko DI; Efimov AC
    Vrach Delo; 1976 Aug; (8):56-8. PubMed ID: 1020293
    [No Abstract]   [Full Text] [Related]  

  • 13. [Causes and the principles of treatment in insulin-dependent diabetes mellitus (type I)].
    Waldhäusl W
    Pol Tyg Lek; 1982 Dec; 37(51-52):1591-4. PubMed ID: 6763993
    [No Abstract]   [Full Text] [Related]  

  • 14. Fat cell size and lipid content of subcutaneous tissue in congenital generalized lipodystrophy.
    Rognum TO; Bjerve KS; Seip M; Trygstad O; Oseid S
    Acta Endocrinol (Copenh); 1978 May; 88(1):182-9. PubMed ID: 580534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful insulin therapy in lipoatrophic diabetes].
    Böhmer K; Hauner H; Phlippen R; Gries FA
    Dtsch Med Wochenschr; 1991 Mar; 116(12):454-9. PubMed ID: 2004587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in Denmark.
    Roze S; de Portu S; Smith-Palmer J; Delbaere A; Valentine W; Ridderstråle M
    Diabetes Res Clin Pract; 2017 Jun; 128():6-14. PubMed ID: 28432898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs.
    Radermecker RP; Piérard GE; Scheen AJ
    Am J Clin Dermatol; 2007; 8(1):21-8. PubMed ID: 17298103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipodystrophy in patients with juvenile dermatomyositis--evaluation of clinical and metabolic abnormalities.
    Huemer C; Kitson H; Malleson PN; Sanderson S; Huemer M; Cabral DA; Chanoine JP; Petty RE
    J Rheumatol; 2001 Mar; 28(3):610-5. PubMed ID: 11296968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When to consider continuous subcutaneous insulin infusion (CSII).
    Drug Ther Bull; 1987 Apr; 25(7):25-8. PubMed ID: 3569048
    [No Abstract]   [Full Text] [Related]  

  • 20. Congenital generalized lipodystrophy.
    Jafri N; Zaidi Z
    J Pak Med Assoc; 1992 Mar; 42(3):74-6. PubMed ID: 1630004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.